nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylergometrine—migraine—Prednisone—psoriatic arthritis	0.939	1	CpDpCtD
Methylergometrine—CYP3A4—Methylprednisolone—psoriatic arthritis	0.00917	0.248	CbGbCtD
Methylergometrine—CYP3A4—Triamcinolone—psoriatic arthritis	0.00695	0.188	CbGbCtD
Methylergometrine—CYP3A4—Betamethasone—psoriatic arthritis	0.00597	0.161	CbGbCtD
Methylergometrine—CYP3A4—Prednisolone—psoriatic arthritis	0.00589	0.159	CbGbCtD
Methylergometrine—CYP3A4—Prednisone—psoriatic arthritis	0.00556	0.15	CbGbCtD
Methylergometrine—CYP3A4—Dexamethasone—psoriatic arthritis	0.00347	0.0938	CbGbCtD
Methylergometrine—Haematuria—Auranofin—psoriatic arthritis	0.000845	0.0354	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.000462	0.0194	CcSEcCtD
Methylergometrine—Abdominal pain—Auranofin—psoriatic arthritis	0.000447	0.0187	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisolone—psoriatic arthritis	0.000423	0.0178	CcSEcCtD
Methylergometrine—Thrombophlebitis—Triamcinolone—psoriatic arthritis	0.000389	0.0163	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methylprednisolone—psoriatic arthritis	0.000389	0.0163	CcSEcCtD
Methylergometrine—Diarrhoea—Auranofin—psoriatic arthritis	0.000387	0.0162	CcSEcCtD
Methylergometrine—Vomiting—Auranofin—psoriatic arthritis	0.000359	0.0151	CcSEcCtD
Methylergometrine—Rash—Auranofin—psoriatic arthritis	0.000356	0.0149	CcSEcCtD
Methylergometrine—Dermatitis—Auranofin—psoriatic arthritis	0.000356	0.0149	CcSEcCtD
Methylergometrine—Thrombophlebitis—Betamethasone—psoriatic arthritis	0.000353	0.0148	CcSEcCtD
Methylergometrine—Thrombophlebitis—Dexamethasone—psoriatic arthritis	0.000353	0.0148	CcSEcCtD
Methylergometrine—Nausea—Auranofin—psoriatic arthritis	0.000336	0.0141	CcSEcCtD
Methylergometrine—Sweating increased—Prednisolone—psoriatic arthritis	0.000309	0.0129	CcSEcCtD
Methylergometrine—Thrombophlebitis—Prednisone—psoriatic arthritis	0.000308	0.0129	CcSEcCtD
Methylergometrine—Sweating increased—Triamcinolone—psoriatic arthritis	0.000284	0.0119	CcSEcCtD
Methylergometrine—Sweating increased—Methylprednisolone—psoriatic arthritis	0.000283	0.0119	CcSEcCtD
Methylergometrine—Bradycardia—Prednisolone—psoriatic arthritis	0.000258	0.0108	CcSEcCtD
Methylergometrine—Sweating increased—Dexamethasone—psoriatic arthritis	0.000258	0.0108	CcSEcCtD
Methylergometrine—Sweating increased—Betamethasone—psoriatic arthritis	0.000258	0.0108	CcSEcCtD
Methylergometrine—Thrombophlebitis—Methotrexate—psoriatic arthritis	0.000257	0.0108	CcSEcCtD
Methylergometrine—Bradycardia—Triamcinolone—psoriatic arthritis	0.000237	0.00996	CcSEcCtD
Methylergometrine—Bradycardia—Methylprednisolone—psoriatic arthritis	0.000237	0.00994	CcSEcCtD
Methylergometrine—Hallucination—Methylprednisolone—psoriatic arthritis	0.000232	0.00971	CcSEcCtD
Methylergometrine—Cerebrovascular accident—Methotrexate—psoriatic arthritis	0.000227	0.00953	CcSEcCtD
Methylergometrine—Sweating increased—Prednisone—psoriatic arthritis	0.000224	0.00941	CcSEcCtD
Methylergometrine—Cardiac disorder—Methylprednisolone—psoriatic arthritis	0.000216	0.00906	CcSEcCtD
Methylergometrine—Bradycardia—Betamethasone—psoriatic arthritis	0.000215	0.00904	CcSEcCtD
Methylergometrine—Bradycardia—Dexamethasone—psoriatic arthritis	0.000215	0.00904	CcSEcCtD
Methylergometrine—Hallucination—Dexamethasone—psoriatic arthritis	0.000211	0.00883	CcSEcCtD
Methylergometrine—Hallucination—Betamethasone—psoriatic arthritis	0.000211	0.00883	CcSEcCtD
Methylergometrine—Convulsion—Prednisolone—psoriatic arthritis	0.000191	0.00803	CcSEcCtD
Methylergometrine—Hypertension—Prednisolone—psoriatic arthritis	0.000191	0.008	CcSEcCtD
Methylergometrine—Bradycardia—Prednisone—psoriatic arthritis	0.000188	0.00787	CcSEcCtD
Methylergometrine—Hallucination—Prednisone—psoriatic arthritis	0.000183	0.00769	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisolone—psoriatic arthritis	0.00018	0.00756	CcSEcCtD
Methylergometrine—Convulsion—Triamcinolone—psoriatic arthritis	0.000176	0.00738	CcSEcCtD
Methylergometrine—Tachycardia—Prednisolone—psoriatic arthritis	0.000176	0.00738	CcSEcCtD
Methylergometrine—Convulsion—Methylprednisolone—psoriatic arthritis	0.000176	0.00736	CcSEcCtD
Methylergometrine—Hypertension—Triamcinolone—psoriatic arthritis	0.000175	0.00735	CcSEcCtD
Methylergometrine—Hypertension—Methylprednisolone—psoriatic arthritis	0.000175	0.00734	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisolone—psoriatic arthritis	0.000174	0.00731	CcSEcCtD
Methylergometrine—Anaphylactic shock—Triamcinolone—psoriatic arthritis	0.000166	0.00695	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methylprednisolone—psoriatic arthritis	0.000165	0.00694	CcSEcCtD
Methylergometrine—Haematuria—Methotrexate—psoriatic arthritis	0.000164	0.00686	CcSEcCtD
Methylergometrine—Nervous system disorder—Methylprednisolone—psoriatic arthritis	0.000162	0.0068	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisolone—psoriatic arthritis	0.000162	0.00679	CcSEcCtD
Methylergometrine—Tachycardia—Triamcinolone—psoriatic arthritis	0.000162	0.00679	CcSEcCtD
Methylergometrine—Tachycardia—Methylprednisolone—psoriatic arthritis	0.000161	0.00677	CcSEcCtD
Methylergometrine—Hyperhidrosis—Triamcinolone—psoriatic arthritis	0.00016	0.00672	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methylprednisolone—psoriatic arthritis	0.00016	0.00671	CcSEcCtD
Methylergometrine—Convulsion—Dexamethasone—psoriatic arthritis	0.00016	0.0067	CcSEcCtD
Methylergometrine—Convulsion—Betamethasone—psoriatic arthritis	0.00016	0.0067	CcSEcCtD
Methylergometrine—Hypertension—Dexamethasone—psoriatic arthritis	0.000159	0.00667	CcSEcCtD
Methylergometrine—Hypertension—Betamethasone—psoriatic arthritis	0.000159	0.00667	CcSEcCtD
Methylergometrine—Hypotension—Methylprednisolone—psoriatic arthritis	0.000154	0.00648	CcSEcCtD
Methylergometrine—Anaphylactic shock—Betamethasone—psoriatic arthritis	0.00015	0.00631	CcSEcCtD
Methylergometrine—Anaphylactic shock—Dexamethasone—psoriatic arthritis	0.00015	0.00631	CcSEcCtD
Methylergometrine—Paraesthesia—Triamcinolone—psoriatic arthritis	0.000149	0.00624	CcSEcCtD
Methylergometrine—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.000148	0.00623	CcSEcCtD
Methylergometrine—Dyspnoea—Triamcinolone—psoriatic arthritis	0.000148	0.0062	CcSEcCtD
Methylergometrine—Nervous system disorder—Betamethasone—psoriatic arthritis	0.000147	0.00619	CcSEcCtD
Methylergometrine—Nervous system disorder—Dexamethasone—psoriatic arthritis	0.000147	0.00619	CcSEcCtD
Methylergometrine—Tachycardia—Dexamethasone—psoriatic arthritis	0.000147	0.00616	CcSEcCtD
Methylergometrine—Tachycardia—Betamethasone—psoriatic arthritis	0.000147	0.00616	CcSEcCtD
Methylergometrine—Hyperhidrosis—Betamethasone—psoriatic arthritis	0.000145	0.0061	CcSEcCtD
Methylergometrine—Hyperhidrosis—Dexamethasone—psoriatic arthritis	0.000145	0.0061	CcSEcCtD
Methylergometrine—Tinnitus—Methotrexate—psoriatic arthritis	0.000144	0.00603	CcSEcCtD
Methylergometrine—Cardiac disorder—Methotrexate—psoriatic arthritis	0.000143	0.006	CcSEcCtD
Methylergometrine—Hypotension—Betamethasone—psoriatic arthritis	0.00014	0.00589	CcSEcCtD
Methylergometrine—Hypotension—Dexamethasone—psoriatic arthritis	0.00014	0.00589	CcSEcCtD
Methylergometrine—Convulsion—Prednisone—psoriatic arthritis	0.000139	0.00583	CcSEcCtD
Methylergometrine—Hypertension—Prednisone—psoriatic arthritis	0.000138	0.00581	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.000135	0.00567	CcSEcCtD
Methylergometrine—Paraesthesia—Betamethasone—psoriatic arthritis	0.000135	0.00566	CcSEcCtD
Methylergometrine—Paraesthesia—Dexamethasone—psoriatic arthritis	0.000135	0.00566	CcSEcCtD
Methylergometrine—Anaphylactic shock—Prednisone—psoriatic arthritis	0.000131	0.00549	CcSEcCtD
Methylergometrine—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.000131	0.00548	CcSEcCtD
Methylergometrine—Nervous system disorder—Prednisone—psoriatic arthritis	0.000128	0.00539	CcSEcCtD
Methylergometrine—Tachycardia—Prednisone—psoriatic arthritis	0.000128	0.00536	CcSEcCtD
Methylergometrine—Hyperhidrosis—Prednisone—psoriatic arthritis	0.000127	0.00531	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.000123	0.00516	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.000123	0.00516	CcSEcCtD
Methylergometrine—Dizziness—Prednisolone—psoriatic arthritis	0.000119	0.005	CcSEcCtD
Methylergometrine—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000119	0.00499	CcSEcCtD
Methylergometrine—Abdominal pain—Betamethasone—psoriatic arthritis	0.000119	0.00499	CcSEcCtD
Methylergometrine—Paraesthesia—Prednisone—psoriatic arthritis	0.000118	0.00493	CcSEcCtD
Methylergometrine—Convulsion—Methotrexate—psoriatic arthritis	0.000116	0.00487	CcSEcCtD
Methylergometrine—Chest pain—Methotrexate—psoriatic arthritis	0.000114	0.00479	CcSEcCtD
Methylergometrine—Rash—Prednisolone—psoriatic arthritis	0.000114	0.00477	CcSEcCtD
Methylergometrine—Dermatitis—Prednisolone—psoriatic arthritis	0.000113	0.00476	CcSEcCtD
Methylergometrine—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000113	0.00475	CcSEcCtD
Methylergometrine—Headache—Prednisolone—psoriatic arthritis	0.000113	0.00474	CcSEcCtD
Methylergometrine—Dizziness—Triamcinolone—psoriatic arthritis	0.00011	0.0046	CcSEcCtD
Methylergometrine—Anaphylactic shock—Methotrexate—psoriatic arthritis	0.000109	0.00459	CcSEcCtD
Methylergometrine—Dizziness—Methylprednisolone—psoriatic arthritis	0.000109	0.00459	CcSEcCtD
Methylergometrine—Nervous system disorder—Methotrexate—psoriatic arthritis	0.000107	0.0045	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000107	0.00449	CcSEcCtD
Methylergometrine—Nausea—Prednisolone—psoriatic arthritis	0.000107	0.00449	CcSEcCtD
Methylergometrine—Hyperhidrosis—Methotrexate—psoriatic arthritis	0.000106	0.00444	CcSEcCtD
Methylergometrine—Vomiting—Triamcinolone—psoriatic arthritis	0.000105	0.00442	CcSEcCtD
Methylergometrine—Vomiting—Methylprednisolone—psoriatic arthritis	0.000105	0.00441	CcSEcCtD
Methylergometrine—Rash—Triamcinolone—psoriatic arthritis	0.000104	0.00438	CcSEcCtD
Methylergometrine—Dermatitis—Triamcinolone—psoriatic arthritis	0.000104	0.00438	CcSEcCtD
Methylergometrine—Rash—Methylprednisolone—psoriatic arthritis	0.000104	0.00437	CcSEcCtD
Methylergometrine—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000104	0.00437	CcSEcCtD
Methylergometrine—Headache—Triamcinolone—psoriatic arthritis	0.000104	0.00436	CcSEcCtD
Methylergometrine—Headache—Methylprednisolone—psoriatic arthritis	0.000104	0.00435	CcSEcCtD
Methylergometrine—Abdominal pain—Prednisone—psoriatic arthritis	0.000103	0.00434	CcSEcCtD
Methylergometrine—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000103	0.00432	CcSEcCtD
Methylergometrine—Diarrhoea—Betamethasone—psoriatic arthritis	0.000103	0.00432	CcSEcCtD
Methylergometrine—Hypotension—Methotrexate—psoriatic arthritis	0.000102	0.00429	CcSEcCtD
Methylergometrine—Dizziness—Dexamethasone—psoriatic arthritis	9.94e-05	0.00417	CcSEcCtD
Methylergometrine—Dizziness—Betamethasone—psoriatic arthritis	9.94e-05	0.00417	CcSEcCtD
Methylergometrine—Nausea—Triamcinolone—psoriatic arthritis	9.84e-05	0.00413	CcSEcCtD
Methylergometrine—Paraesthesia—Methotrexate—psoriatic arthritis	9.82e-05	0.00412	CcSEcCtD
Methylergometrine—Nausea—Methylprednisolone—psoriatic arthritis	9.82e-05	0.00412	CcSEcCtD
Methylergometrine—Dyspnoea—Methotrexate—psoriatic arthritis	9.75e-05	0.00409	CcSEcCtD
Methylergometrine—Vomiting—Betamethasone—psoriatic arthritis	9.56e-05	0.00401	CcSEcCtD
Methylergometrine—Vomiting—Dexamethasone—psoriatic arthritis	9.56e-05	0.00401	CcSEcCtD
Methylergometrine—Rash—Dexamethasone—psoriatic arthritis	9.48e-05	0.00398	CcSEcCtD
Methylergometrine—Rash—Betamethasone—psoriatic arthritis	9.48e-05	0.00398	CcSEcCtD
Methylergometrine—Dermatitis—Dexamethasone—psoriatic arthritis	9.47e-05	0.00397	CcSEcCtD
Methylergometrine—Dermatitis—Betamethasone—psoriatic arthritis	9.47e-05	0.00397	CcSEcCtD
Methylergometrine—Headache—Betamethasone—psoriatic arthritis	9.42e-05	0.00395	CcSEcCtD
Methylergometrine—Headache—Dexamethasone—psoriatic arthritis	9.42e-05	0.00395	CcSEcCtD
Methylergometrine—Diarrhoea—Prednisone—psoriatic arthritis	8.96e-05	0.00376	CcSEcCtD
Methylergometrine—Gastrointestinal pain—Methotrexate—psoriatic arthritis	8.95e-05	0.00375	CcSEcCtD
Methylergometrine—Nausea—Dexamethasone—psoriatic arthritis	8.93e-05	0.00375	CcSEcCtD
Methylergometrine—Nausea—Betamethasone—psoriatic arthritis	8.93e-05	0.00375	CcSEcCtD
Methylergometrine—Dizziness—Prednisone—psoriatic arthritis	8.66e-05	0.00363	CcSEcCtD
Methylergometrine—Abdominal pain—Methotrexate—psoriatic arthritis	8.65e-05	0.00363	CcSEcCtD
Methylergometrine—Vomiting—Prednisone—psoriatic arthritis	8.32e-05	0.00349	CcSEcCtD
Methylergometrine—Rash—Prednisone—psoriatic arthritis	8.25e-05	0.00346	CcSEcCtD
Methylergometrine—Dermatitis—Prednisone—psoriatic arthritis	8.25e-05	0.00346	CcSEcCtD
Methylergometrine—Headache—Prednisone—psoriatic arthritis	8.2e-05	0.00344	CcSEcCtD
Methylergometrine—Nausea—Prednisone—psoriatic arthritis	7.78e-05	0.00326	CcSEcCtD
Methylergometrine—Diarrhoea—Methotrexate—psoriatic arthritis	7.49e-05	0.00314	CcSEcCtD
Methylergometrine—Dizziness—Methotrexate—psoriatic arthritis	7.24e-05	0.00304	CcSEcCtD
Methylergometrine—Vomiting—Methotrexate—psoriatic arthritis	6.96e-05	0.00292	CcSEcCtD
Methylergometrine—Rash—Methotrexate—psoriatic arthritis	6.9e-05	0.00289	CcSEcCtD
Methylergometrine—Dermatitis—Methotrexate—psoriatic arthritis	6.89e-05	0.00289	CcSEcCtD
Methylergometrine—Headache—Methotrexate—psoriatic arthritis	6.85e-05	0.00288	CcSEcCtD
Methylergometrine—Nausea—Methotrexate—psoriatic arthritis	6.5e-05	0.00273	CcSEcCtD
